Skip to main content
Equibles
NRXP logo

NRXP · NRX Pharmaceuticals, Inc. · Exempt Offerings

Track NRXP — free

Use NRXP with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.39 -0.09 (-2.45%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least twelve months from the date of issuance of these consolidated financial statements.”
View the 10-Q filed Aug 14, 2026
Market Cap
$151.10M
Shares
43.30M

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2025-03-07 New $3,500,000 $3,500,000
Showing 1–1 of 1 filings
Key facts CIK 1719406 CUSIP 629444209 13F (30d) 33 filings 33 filers Visit website Investor relations